MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
IBIO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

iBio (IBIO) Ownership - Who owns iBio?

iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
83.96M
P/E Ratio
0.65
Total Cash
74.8M
Projected Growth
N/A
Total Debt
2.33M
Revenue
300K
Risk (Beta)
1.24
Dividend Yield
N/A
Total Cash/Share
1.51
Total Debt/Equity
N/A
Revenue/Share
0.00 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
IBIO
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for IBIO
A.I. Advisor
published General Information

General Information

a company which engages in the development and commercialization of vaccines and therapeutic proteins

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A